Pre-operative Aqueous Antiseptic Skin Solutions in Open Fractures

• Status: Active, not recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The prevention of infection is the single most important goal influencing peri-operative care of patients with open fractures. Standard practice in the management of open fractures includes sterile technique and pre-operative skin preparation with an antiseptic solution. The available solutions kill bacteria and decrease the quantity of native skin flora, thereby decreasing surgical site infection (SSI). While there is extensive guidance on specific procedures for prophylactic antibiotic use and standards for sterile technique, the evidence regarding the choice of antiseptic skin preparation solution is very limited for open fracture surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of Maryland; University of Maryland, Baltimore
• Collaborators: McMaster University; United States Department of Defense
• Treatments: Anti-Infective Agents, Local; Cadexomer iodine; Chlorhexidine; Chlorhexidine gluconate; Iodine; Pharmaceutical Solutions; Povidone; Povidone-Iodine

Criteria

The inclusion criteria are:

1. Patients 18 years of age or older.

2. Open fracture of the appendicular skeleton.

3. Received or will receive definitive fracture treatment with a surgical implant(s) (e.g., internal fixation, external fixation, joint prosthesis, etc.).

4. Open fracture wound management that includes formal surgical debridement within 72 hours of their injury.

5. Will have all planned fracture care surgeries performed by a participating surgeon or delegate.

6. Informed consent obtained.

7. Patient enrolled within 3 weeks of their fracture.

The exclusion criteria are:

1. Patients that did not or will not receive the allocated pre-operative surgical preparation solution due to a medical contraindication.

2. Received previous surgical debridement or management of their open fracture at a non-participating hospital or clinic.

3. Open fracture managed outside of the participating orthopaedic service (e.g., hand fracture managed by plastic surgeon).

4. Chronic or acute infection at or near the fracture site at the time of initial fracture surgery.

5. Burns at the fracture site.

6. Incarceration.

7. Expected injury survival of less than 90 days.

8. Terminal illness with expected survival less than 90 days.

9. Previous enrollment in a PREP-IT trial.

10. Currently enrolled in a study that does not permit co-enrollment.

11. Unable to obtain informed consent due to language barriers.

12. Likely problems, in the judgment of study personnel, with maintaining follow-up with the patient.

13. Excluded due to sampling strategy.